Final results of the study of safety and tolerability of simulect® (basiliximab)versus OKT3 in heart transplantation
J.L Rodríguez Lambert, M.G Crespo Leiro, J Segovia, L Almenar, E Roig, M.A Gómez Sánchez, E Lage, N Manito, L.A PulpónVolume:
23
Year:
2004
Language:
english
DOI:
10.1016/j.healun.2003.11.211
File:
PDF, 84 KB
english, 2004